TY  - JOUR
PY  - 2003//
TI  - Donepezil in the treatment of mild to moderate Alzheimer's disease: Report of a Belgian multicenter study
JO  - Acta neurologica Belgica
A1  - Santens, P.
A1  - Ventura, M.
SP  - 159
EP  - 163
VL  - 103
IS  - 3
N2  - In this report the results of a Belgian multicenter 24-week open-label study with donepezil in the treatment of mild to moderate Alzheimer's disease are described. Efficacy and safety were evaluated in a sample of 200 patients recruited in 25 Belgian centers. No significant changes could be found in cognition and behaviour over this 6-month period. Changes in daily functioning were small. Safety data were comparable to those reported in international trials. These results suggest that the findings of more robust double-blind, placebo-controlled studies can be confirmed in real life situations.<p /> <p>Language: en</p>
LA  - en
SN  - 0300-9009
UR  - http://dx.doi.org/
ID  - ref1
ER  -